Publication Name	World Journal of Hepatology
Manuscript ID	21483
Country	Canada

Received	2015-07-21 08:20
Peer-Review Started	2015-07-22 09:26
First Decision by Editorial Office Director
Return for Revision	2015-08-25 19:00
Revised	2015-10-02 23:04
Publication Fee Transferred
Second Decision by Editor	2015-11-17 15:16
Second Decision by Editor-in-Chief	2015-11-17 22:08
Final Decision by Editorial Office Director	2015-12-02 14:27
Articles in Press	2015-12-02 14:27
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-12-06 17:12
Publish the Manuscript Online	2015-12-10 15:03

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Review
Article Title	Recurrence of autoimmune liver diseases after liver transplantation
Manuscript Source	Invited Manuscript
All Author List	Nabiha Faisal and Eberhard L Renner
Funding Agency and Grant Number
Corresponding Author	Eberhard L Renner, MD, FRCP(C), Professor of Medicine, Director GI Transplantation, Liver Transplant Program/Multiorgan Transplant Program, University Health Network/Toronto General Hospital, University of Toronto, 585 University Avenue, 11 PMB 176, Toronto, ON M5G 2N2, Canada. eberhard.renner@uhn.ca
Key Words	Recurrent autoimmune hepatitis; Recurrent primary biliary cirrhosis; Recurrent primary sclerosing cholangitis; Liver transplantation; Immunosuppression; Risk factors; Outcomes; Autoimmune liver diseases
Core Tip	There is compelling evidence that autoimmune liver disease recur after liver transplantation, with incidence rates ranging from 10% to 50%. Recurrent autoimmune hepatitis and primary biliary cirrhosis do rarely impair patient and graft survival, but may require changing the immunosuppressive regimen, using corticosteroids or adding ursodeoxycholic acid, respectively. In a proportion of patients, recurrent primary sclerosing cholangitis progresses over years to a stage requiring re-transplantation.
Publish Date	2015-12-10 15:03
Citation	Faisal N, Renner EL. Recurrence of autoimmune liver diseases after liver transplantation. World J Hepatol 2015; 7(29): 2896-2905
URL	http://www.wjgnet.com/1948-5182/full/v7/i29/2896.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i29.2896

Full Article (PDF)	WJH-7-2896.pdf
Full Article (Word)	WJH-7-2896.doc
Manuscript File	21483-Review.doc
Answering Reviewers	21483-Answering reviewers.pdf
Audio Core Tip	21483-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	21483-Conflict-of-interest statement.pdf
Copyright License Agreement	21483-Copyright assignment.pdf
Peer-review Report	21483-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	21483-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	21483-Scientific misconduct check.pdf
Scientific Editor Work List	21483-Scientific editor work list.pdf